Vai offline con l'app Player FM !
Exploring the Role of GABA and Serotonin in Brain Disorders: Dr. Rochelle Hines on Neurotransmitters, Psychedelics, and Personalized Therapies
Manage episode 444259287 series 3493690
Dr. Rochelle Hines, an NIH-funded principal investigator at UNLV, discusses her journey into neuroscience, focusing on neurotransmitter systems and their roles in brain disorders. She highlights the importance of GABA, the major inhibitory neurotransmitter, in brain development and its role in disorders like schizophrenia. Hines also explores the interplay between serotonin and GABA, particularly in the context of psychedelics and their therapeutic potential. She emphasizes the need for modulatory therapies over binary on/off approaches, citing her work with synthetic cannabidiol enantiomers and the founding of Tesla Therapeutics. Hines stresses the importance of personalized medicine and the need for better biomarkers in mental health treatments.
24 episodi
Manage episode 444259287 series 3493690
Dr. Rochelle Hines, an NIH-funded principal investigator at UNLV, discusses her journey into neuroscience, focusing on neurotransmitter systems and their roles in brain disorders. She highlights the importance of GABA, the major inhibitory neurotransmitter, in brain development and its role in disorders like schizophrenia. Hines also explores the interplay between serotonin and GABA, particularly in the context of psychedelics and their therapeutic potential. She emphasizes the need for modulatory therapies over binary on/off approaches, citing her work with synthetic cannabidiol enantiomers and the founding of Tesla Therapeutics. Hines stresses the importance of personalized medicine and the need for better biomarkers in mental health treatments.
24 episodi
Tutti gli episodi
×Benvenuto su Player FM!
Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.